|

Dupilumab Clinical Trials

10 actively recruiting trials across 4 locations

▲ +1 trial since August 2026

Also known as: DUPIXENT, Dupixent, Dupixent®, REGN668, SAR231893

Pipeline

Early 1: 1Phase 4: 3Phase 1/2: 2

Top Sponsors

  • Sanofi3
  • University of California, San Diego1
  • Sally E. Wenzel MD1
  • Rima Patel1
  • Medical University of Vienna1

Indications

Other4 trials

DETACT sEvere asThmAtiC paTients - a Pilot Study
Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer
N/A
Study to Evaluate Long-term Effectiveness and Safety, Patient Characteristics and Subjective Patient-reported Outcomes of Dupilumab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Under Real-world Conditions
The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis

New York, New York3 trials

Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC

Icahn School of Medicine at Mount Sinai

Phase 1/2
Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases

Icahn School of Medicine at Mount Sinai

Phase 1/2
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer

Mount Sinai Health System

Early 1

Birmingham, Alabama1 trial

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

University of Alabama at Birmingham - School of Medicine- Site Number : 8400003

Phase 4

Scottsdale, Arizona1 trial

Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping

Mayo Clinic

Phase 4

Pittsburgh, Pennsylvania1 trial

Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma

The University of Pittsburgh Asthma Institute at UPMC

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.